We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Topical cosmetic ingredient — not a dietary supplement
Polyhydroxy Acids (PHA) is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Polyhydroxy Acids (PHA) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2004–2010 with a typical study size of 77 participants.
Based on 6 studies · 2 RCTs · 77 total participants
Confidence
LowBy outcome
Polyhydroxy Acids (PHA) has an evidence score of 4/10 — emerging evidence based on 6 indexed studies. A gentler, next-generation family of exfoliating acids (gluconolactone, lactobionic acid) applied to the skin — a cosmetic, not ingested. Because PHA molecules are larger than AHAs like glycolic acid, they penetrate more slowly and irritate less, while adding humectant and antioxidant properties. The honest framing: in head-to-head trials PHAs deliver anti-aging benefits comparable to AHAs with notably better tolerability — their real, evidence-backed niche is gentleness for sensitive and rosacea-prone skin. But the efficacy evidence is thin, older (mostly 2004–2010), and heavily industry-originated; there are no large modern independent RCTs, and effects are modest and roughly match or slightly trail AHAs. Representative study: PMID 15002657.
The commonly studied dose of Polyhydroxy Acids (PHA) is Topical cosmetic only. PHAs (gluconolactone, lactobionic acid) are used in leave-on toners, serums, and creams applied to clean skin, typically building from a few times weekly to daily as tolerated; sunscreen is recommended. There is no oral or systemic dose — they are not ingested. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Explore: Best supplements for Skin, Hair & Beauty
Last reviewed June 2026 · evidence from 6 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Polyhydroxy Acids (gluconolactone, lactobionic acid)
A gentler, next-generation family of exfoliating acids (gluconolactone, lactobionic acid) applied to the skin — a cosmetic, not ingested. Because PHA molecules are larger than AHAs like glycolic acid, they penetrate more slowly and irritate less, while adding humectant and antioxidant properties. The honest framing: in head-to-head trials PHAs deliver anti-aging benefits comparable to AHAs with notably better tolerability — their real, evidence-backed niche is gentleness for sensitive and rosacea-prone skin. But the efficacy evidence is thin, older (mostly 2004–2010), and heavily industry-originated; there are no large modern independent RCTs, and effects are modest and roughly match or slightly trail AHAs.
Coherent mechanism (gentler exfoliation, humectant, antioxidant/barrier acidification) and head-to-head trials showing anti-aging comparable to AHAs with better tolerability — but the efficacy evidence is thin, older (2004-2010), heavily industry-originated, with no large modern independent RCTs and modest effects that match or slightly trail AHAs.
Polyhydroxy acids (PHAs) — chiefly gluconolactone and the bionic acid lactobionic acid — are a 'next-generation' class of exfoliating acids designed to deliver alpha-hydroxy-acid-like benefits with less irritation. This entry covers TOPICAL cosmetic use.
Their defining feature is molecular size: PHAs are larger (and lactobionic acid is a disaccharide derivative) so they penetrate the stratum corneum more slowly and gently than glycolic acid, and they add humectant, metal-chelating, and antioxidant properties.
The mechanism is reasonably characterized: gluconolactone provided up to ~50% protection against UV-induced changes in an in-vitro photoaging model without increasing sunburn cells in human skin (Bernstein et al., 2004), and an independent preclinical study showed PHAs acidify the stratum corneum to improve barrier lipid processing and corneodesmosome integrity (Hachem et al., 2010).
On efficacy, the key controlled trial (Edison et al., 2004) found a gluconolactone (PHA) regimen produced anti-aging benefits comparable to a glycolic acid (AHA) regimen on silicone replicas, clinical grading, and pinch recoil — with significantly less stinging and burning; AHA modestly beat PHA on only 2 of the measured endpoints.
An independent bioengineering trial (Tasic-Kostov et al., 2010; n=77) found lactobionic acid outperformed glycolic acid on tolerability with no barrier impairment.
The honest caveats: the pivotal efficacy trial and a supporting review share NeoStrata (industry) authorship, an independent FDA/NIH review notes hydroxy-acid mechanisms 'still require more clarification,' samples are small (n≈24-77), the evidence clusters in 2004-2010, and there are no large modern independent RCTs with hard photoaging endpoints.
So the honest summary: PHAs are a well-tolerated, gentler alternative to AHAs with comparable (not superior) modest anti-aging effects and a genuine niche in sensitive/rosacea-prone skin, on a thin and partly industry-originated evidence base. None of this is a health claim.
It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
PHAs (gluconolactone, lactobionic acid) are larger molecules than AHAs, so they penetrate the stratum corneum more slowly and exfoliate with less irritation. Independent work shows they acidify the stratum corneum to improve barrier-lipid processing and corneodesmosome integrity.
PHAs are also humectants and metal chelators with antioxidant activity; gluconolactone provided up to ~50% protection against UV-induced changes in an in-vitro photoaging model — properties that distinguish them from simple AHA exfoliation and support the sensitive-skin niche.
Topical cosmetic only. PHAs (gluconolactone, lactobionic acid) are used in leave-on toners, serums, and creams applied to clean skin, typically building from a few times weekly to daily as tolerated; sunscreen is recommended. There is no oral or systemic dose — they are not ingested. This library does not provide an ingestion protocol.
| Form | Type |
|---|---|
| 🧴Leave-on PHA toner, serum, or cream (gluconolactone or lactobionic acid) | Recommended |
| 💊AHAs (glycolic, lactic) when tolerability is less of a concern and more potency is wanted | Alternative |
There is no oral or injectable cosmetic form. PHAs are applied to the skin surface.
Minimum: 4 weeks
Optimal: 12 weeks
Cycling: Not required
Note: Applied to clean skin, building frequency as tolerated. As a leave-on cosmetic there is no ingestion or meal-timing consideration; daily sunscreen is recommended with exfoliating acids.
PHAs deliver AHA-like exfoliation and anti-aging with less irritation. They are topical cosmetic ingredients, not ingested supplements, and their hallmark is tolerability.
Improves texture and the look of photoaged skin comparably to AHAs, with significantly less stinging and burning — a good option where AHAs are too irritating.
Lower irritation and no barrier impairment in head-to-head studies make PHAs compatible with sensitive, rosacea-prone, and post-procedure skin.
Efficacy data are small, clustered in 2004-2010, and the pivotal trial is industry-authored; PHAs match rather than beat AHAs. Value them for gentleness, not potency.
Topical PHAs have minimal absorption and are generally considered low-concern; discuss your routine with a clinician.
Often the preferred exfoliating acid here — lower irritation with no barrier impairment in studies.
AHAs may work a bit faster; PHAs trade a little potency for gentleness.
PHAs are gentler but still exfoliating; combining with other acids/retinoids can add irritation. Introduce one at a time. Not a systemic interaction — they are not ingested.
Tip: Generally gentler than AHAs; reduce frequency if irritation occurs.
Timing is flexible for Polyhydroxy Acids (PHA) — consistent daily use matters more than the time of day. PHAs are leave-on exfoliants with no meal-timing relationship; gentler than AHAs, they can be used AM or PM, though daily sunscreen is recommended with any exfoliating acid.
Polyhydroxy Acids (PHA) is generally well-tolerated and considered safe for most healthy adults at recommended doses. The most commonly reported side effects are mild stinging or dryness. Use caution if any of these apply to you: For topical (skin) use only — not for ingestion, not for injection; Known allergy or sensitivity to the formulation; Active dermatitis or broken/sunburned skin until healed.
Daily broad-spectrum sunscreen — the single most evidence-based anti-aging skincare step there is, and the one most 'anti-aging' actives are really just trying to compensate for. The honest framing: this is the only topical on this list backed by a proper randomized controlled trial for skin aging itself. In the landmark Hughes 2013 trial (n=903), people randomized to daily sunscreen showed 24% less photoaging over 4.5 years — and no detectable increase in skin aging at all — while the mechanism (UV → matrix-metalloproteinase activation → collagen breakdown) is textbook. The same trial cohort also had less skin cancer. The honest caveats: the benefit is overwhelmingly prevention, not reversal of existing damage; real-world results depend entirely on applying enough and reapplying; and chemical (organic) UV filters are systemically absorbed above an FDA testing threshold (clinical significance unknown — mineral zinc-oxide/titanium-dioxide filters sidestep this). If you do one thing for your skin, it's this.